text_1: Novartis Drug Curbs Repeat Hip Fractures
text_2: This was an interesting story about treatment for an undertreated population of individuals. It defined the population (mostly women with an average age of 74 who had had a hip fracture – but it could have mentioned that 90% were white) and defined that the endpoint was a reduction in the number who died during the study period and that those in the treated group had a lower risk of dying as well as a smaller overall risk of subsequent bone fracture. In only 482 words, the story addressed most of our criteria, failing only to discuss costs and to quantify harms.